Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation.
about
Effect of redox modulating NRF2 activators on chronic kidney diseaseOxidative Stress and Treg and Th17 Dysfunction in Systemic Lupus ErythematosusNatural Compounds as Regulators of NLRP3 Inflammasome-Mediated IL-1β ProductionInflammasomes and Natural Ingredients towards New Anti-Inflammatory AgentsNrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-κB-mediated inflammatory responseThe complexity of the Nrf2 pathway: beyond the antioxidant responseCitral alleviates an accelerated and severe lupus nephritis model by inhibiting the activation signal of NLRP3 inflammasome and enhancing Nrf2 activationCitral is renoprotective for focal segmental glomerulosclerosis by inhibiting oxidative stress and apoptosis and activating Nrf2 pathway in miceBamboo vinegar decreases inflammatory mediator expression and NLRP3 inflammasome activation by inhibiting reactive oxygen species generation and protein kinase C-α/δ activationPolyenylpyrrole derivatives inhibit NLRP3 inflammasome activation and inflammatory mediator expression by reducing reactive oxygen species production and mitogen-activated protein kinase activationDemethylzeylasteral (T-96) Treatment Ameliorates Mice Lupus Nephritis Accompanied by Inhibiting Activation of NF-κB PathwayLupus nephritis: glycogen synthase kinase 3β promotion of renal damage through activation of the NLRP3 inflammasome in lupus-prone mice.NRF2 Plays a Critical Role in Both Self and EGCG Protection against Diabetic Testicular Damage.The inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis?Natural compounds and aging: between autophagy and inflammasome.The emerging role of the inflammasome in kidney diseasesHigh beta-palmitate fat controls the intestinal inflammatory response and limits intestinal damage in mucin Muc2 deficient mice.Lycopene attenuates colistin-induced nephrotoxicity in mice via activation of the Nrf2/HO-1 pathway.Screening of natural compounds as activators of the keap1-nrf2 pathway.Green tea polyphenol (-)-epigallocatechin-3-gallate restores Nrf2 activity and ameliorates crescentic glomerulonephritisTargeting the inflammasome in rheumatic diseases.Monosodium urate crystals trigger Nrf2- and heme oxygenase-1-dependent inflammation in THP-1 cells.Targeting HO-1 by Epigallocatechin-3-Gallate Reduces Contrast-Induced Renal Injury via Anti-Oxidative Stress and Anti-Inflammation Pathways.Green Tea Epigallocatechin-3-Gallate Suppresses Autoimmune Arthritis Through Indoleamine-2,3-Dioxygenase Expressing Dendritic Cells and the Nuclear Factor, Erythroid 2-Like 2 Antioxidant Pathway.Green tea polyphenol epigallocatechin-3-gallate suppresses melanoma growth by inhibiting inflammasome and IL-1β secretion.Isoflurane attenuates murine lupus nephritis by inhibiting NLRP3 inflammasome activation.Activation of NRF2 Signaling in HEK293 Cells by a First-in-Class Direct KEAP1-NRF2 Inhibitor.Redox homeostasis, T cells and kidney diseases: three faces in the dark.The Therapeutic Effects of the Chinese Herbal Medicine, Lang Chuang Fang Granule, on Lupus-Prone MRL/lpr Mice.Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney diseasePrevention of murine lupus nephritis by targeting multiple signaling axes and oxidative stress using a synthetic triterpenoid.Exacerbated airway toxicity of environmental oxidant ozone in mice deficient in Nrf2.Nuclear factor erythroid 2-related factor 2 is a critical target for the treatment of glucocorticoid-resistant lupus nephritis.Serum IL-18 as biomarker in predicting long-term renal outcome among pediatric-onset systemic lupus erythematosus patients.Targeting ASC in NLRP3 inflammasome by caffeic acid phenethyl ester: a novel strategy to treat acute gout.3,4-Dihydroxytoluene, a metabolite of rutin, inhibits inflammatory responses in lipopolysaccharide-activated macrophages by reducing the activation of NF-κB signaling.Selective IRAK4 Inhibition Attenuates Disease in Murine Lupus Models and Demonstrates Steroid Sparing Activity.Mitochondrial dysfunction and oxidative stress activate inflammasomes: impact on the aging process and age-related diseases.Canonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis.New approaches for the treatment of lupus nephritis in the 21st century: from the laboratory to the clinic.
P2860
Q26827726-686C8D6E-0945-4276-BAFD-BC7B13082A62Q28071300-AC21801B-625A-4194-B4FB-4E2AB40966D1Q28072287-60579B78-737E-474C-B636-5A80C0894818Q28080119-1304309A-A054-438E-B3DF-457BC77AABE1Q28384306-58C9F0AE-08FE-4BCE-A278-F2E67F5C501BQ28389296-07F568E5-3F4F-489A-B289-2CD06E6E5C6CQ28394337-A015991B-B7C2-4F97-B957-AFD61867A32EQ28533529-D60BF362-3295-411B-9AF1-A3D6374653FFQ28534131-8348DB1B-3A33-401F-A655-D8DD2E535EAFQ28534137-80EE0371-B1B0-4259-8749-5BDB2C915408Q28546765-0D932487-27DF-4BF7-A71B-A2673074F25AQ30361236-6DDE38D3-FF04-48F5-9DDC-0A8974637C56Q33862451-8250A38A-CC8C-498A-B190-44885AFA4C4FQ34127758-E677EFA2-3C92-4851-A26D-C61E218EC20BQ34266337-B2E0394A-4EED-48EE-8998-CFA0AB47442FQ34307043-272DB6AB-C663-4735-BA75-627CDA9FB095Q34776025-D73D707F-910E-469C-B52B-E5E7AC6B3334Q34922961-374ED479-2977-419C-9C50-79B00B1367A5Q35059810-F0D48A24-5DD1-417F-8345-3BE64A909AE0Q35191850-B151E95A-247C-44DE-9B0D-6643B4BA09E3Q35804717-435CD731-8FB2-4382-BD91-CFF7727869E5Q35833620-CB2E45D9-773D-438C-80DC-68E81860A62FQ35920544-626CBED7-6CEF-4E12-9D65-BF67A984F5C4Q36062141-57A97B9C-98EF-4D3F-88B3-6AB4ABFEC3F8Q36199584-E9BBEA01-A863-4B4C-9A0B-91E63F91B3A9Q36411613-E2D37C8E-893A-4FC9-BD4F-699C2083206FQ36463474-306CC97C-9169-42C5-B5C4-EF21AAEC6F2FQ36482958-CB661FBA-2C17-4C6C-A9E7-FEA8F23823C1Q36681089-EE352681-DD91-4CC7-B907-7D4B7B07E559Q36788430-C8AF982D-C5F3-4CD3-B644-C3CE87004446Q36823420-2BC9A9BC-A57D-48BC-9A8A-58ACC1828F95Q36879929-55F9158F-066A-468B-8CC9-939C55DF2CC7Q37006437-45FDFA3B-8CDA-40B4-ABDF-1189F4F6AF76Q37328887-309223FF-384E-4068-B8D0-A3ECC72EF7DEQ37488147-0CBDA44F-9D62-40CD-A874-DE8855C54CA4Q37509899-1CE093DF-134A-42E7-8BFE-D8F5E66B4B40Q37598017-90CA577C-D97A-4123-8509-616221082A73Q37996828-5B4C926D-BD8C-426A-9075-23D2B4E67E1BQ38136506-7D6FB095-DA26-42BC-ABF4-2CA493F87FB9Q38148585-865CD64D-4162-4A2F-AF5D-BEA46D6CFD9C
P2860
Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Epigallocatechin-3-gallate pre ...... NLRP3 inflammasome activation.
@en
Epigallocatechin-3-gallate pre ...... NLRP3 inflammasome activation.
@nl
type
label
Epigallocatechin-3-gallate pre ...... NLRP3 inflammasome activation.
@en
Epigallocatechin-3-gallate pre ...... NLRP3 inflammasome activation.
@nl
prefLabel
Epigallocatechin-3-gallate pre ...... NLRP3 inflammasome activation.
@en
Epigallocatechin-3-gallate pre ...... NLRP3 inflammasome activation.
@nl
P2093
P1476
Epigallocatechin-3-gallate pre ...... NLRP3 inflammasome activation.
@en
P2093
Chen-Yun Li
Hao-Ai Shui
Jia-Ming Chang
Jiann-Jyh Huang
Kuo-Feng Hua
Pei-Yi Tsai
Shuk-Man Ka
Sung-Sen Yang
Wen-Liang Chang
P304
P356
10.1016/J.FREERADBIOMED.2011.05.016
P577
2011-05-23T00:00:00Z